Background: Recent attention has focused on the question of how quickly antiretroviral
therapy (ART) should be started once HIV diagnosis is confirmed. We assessed whether rapid …

Background Multidrug-resistant (MDR) Mycobacterium tuberculosis complex strains not
detected by commercial molecular drug susceptibility testing (mDST) assays due to the RpoB …

Background Studies have shown that early ART initiation in TB/HIV co-infected patients lowers
mortality. One way to implement earlier ART commencement could be through integration …

Objectives To evaluate the feasibility (population reached, costs) and effectiveness (positivity
rates, linkage to care) of two strategies of community‐based HIV testing and counselling ( …

Introduction As antiretroviral therapy ( ART ) is scaled up, more patients become eligible for
routine viral load ( VL ) monitoring, the most important tool for monitoring ART efficacy. For …

Background HIV-1 drug resistance to older thymidine analogue nucleoside reverse transcriptase
inhibitor drugs has been identified in sub-Saharan Africa in patients with virological …

Rapid initiation of antiretroviral therapy (ART) is recommended for people living with human
immunodeficiency virus (HIV), with the option to start treatment on the day of diagnosis (…

Objective: To assess the programmatic quality (coverage of testing, counseling, and
retesting), cost, and outcomes (viral suppression, treatment decisions) of routine viral load (VL) …

“Treat-all” programmes aim to improve clinical outcomes and to reduce HIV transmission
through regular HIV testing and immediate offer of antiretroviral therapy (ART) for those …

Background Universal antiretroviral therapy (ART) for all pregnant/ breastfeeding women
living with Human Immunodeficiency Virus (HIV), known as Prevention of mother-to child …